A rigorous randomized clinical trial of rizatriptan conducted by UCLA and Mayo Clinic researchers failed to outperform placebo in relieving the acute symptoms of vestibular migraine.
This article was originally published on MedicalXpress.com
Rizatriptan shows no advantage over placebo within first hour for vestibular migraine
You may also be interested in:
The Latest
Avoiding Common Relationship Mistakes for a Happier Love Life
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
The Latest
5 Popular Supplements in Canada for Optimal Health and Wellness
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Read More:
-
Children born to mothers who are very obese with a BMI of 35 or higher are at heightened risk of being admitted to hospital for [...]
-
Pregnancy and birth rates among Minnesota youth have reached their lowest levels since 1990, continuing a decades-long decline, according to the newly released 2025 Minnesota [...]
-
Researchers have found that green space exposure is associated with widespread patterns of structural brain development during early adolescence, which in turn are associated with [...]
